New York, NY: Confido Health has raised $10 million in a Series A funding round to expand its AI-powered voice agent platform designed specifically for healthcare. With this round, the company’s total funding reaches $13 million.
The investment was led by Blume Ventures, with participation from Schema Ventures, Vicus Ventures, and existing investors Together Fund, DeVC, and Medmountain Ventures. Strategic healthcare operators from Innovaccer, Memora Health, and a roster of Confido customers also joined the round.
Confido Health Expands AI Voice Agent Platform
Confido Health is addressing one of the most pressing challenges in healthcare – patient communication. Despite advancements in digital tools, 81% of patients in 2025 still rely on phone calls to connect with providers, leading to delays, long wait times, and staff burnout.
Also Read: SuperDial Secures USD 15 Million to Expand AI Voice Agents in Healthcare
Confido Health’s AI-driven platform replaces traditional phone systems, enabling instant responses, authentication, eligibility checks, and resolutions for tasks such as referrals, refills, intake, payments, status updates, and appointment bookings.
Complex cases are seamlessly transferred to staff, and every interaction is documented within EHR or PMS systems.
Confido Health Reports Rapid Growth
In the last eight months, Confido Health has expanded 10x, now offering 24/7 access to more than 1 million patients, compared to just 150,000 in December 2024.
The company achieves automation rates above 80%, enabling practices to resolve queries faster and free up staff for higher-value work.
For providers, particularly multi-site operators and private equity-backed groups, Confido Health offers a unified patient experience while reducing overhead and scaling efficiently.
Also Read: Vaani AI Research Secures USD 400K Pre-Seed Round Led by Venture Catalysts
Confido Health’s platform is already live across specialties such as pediatrics, orthopedics, GI, nephrology, dermatology, and pain medicine.
At Dallas Renal Group, outbound call confirmation rates reached 66%, with less than 6% requiring staff intervention. Inbound wait times dropped to 15 seconds, saving nearly 50 staff hours in a single week.
“Healthcare is at an inflection point,” said Chetan Reddy, Co-founder and CEO of Confido Health. “Labor shortages and patient demand mean practices cannot keep scaling front desks as before. Our AI agents are designed to support staff and patients, ensuring faster access and reduced stress.”
Sanjay Nath, Partner at Blume Ventures, stated: “Confido Health is transforming patient communication with providers. Given administrative staff shortages in healthcare, we see a clear path for Confido to become a market leader in AI-driven patient experience.”
Shubham Gupta, Founding General Partner at Together Fund, added: “The Confido Health team has developed a generative, multi-agent platform that tackles patient access challenges where legacy vendors and EHRs have failed. Their focus on data and integrations sets them apart.”
Future Roadmap
Confido Health plans to expand beyond scheduling and intake into recalls, reactivation, payments, and care coordination.
With specialty playbooks, audit trails, analytics, and first-call resolution metrics, the platform aims to become the infrastructure layer for patient communication across healthcare providers of all sizes.
